STM publisher Elsevier, Netherlands, has announced that its journal Vaccine will organise the 3rd Vaccine Global Congress from October 4-6, 2009, in Singapore. For those who cannot attend the congress, Elsevier is organising Vaccine Virtual. The interactive event will allow people to sample - from their desk – the content and networking opportunities provided by the congress and exhibition.
Last year, the event was held in Boston. The meeting in Singapore will seek to serve as an international interface between academics in research and development, regulatory and governmental agencies, charities, and health and industry professionals.
The congress is organised in collaboration with the International Society for Vaccines. Both GSK and Novartis will present their latest data on H1N1 flu vaccine research. To supplement a number of invited keynote speakers, multiple oral and poster presentations have been selected to cover all facets of vaccinology, including: human vaccines for infectious and non-infectious diseases, veterinary vaccines, adjuvants, drug delivery, production, safety and regulatory aspects.
In addition, Elsevier is offering a taste of the 3rd Vaccine Global Congress by video broadcasting live and on-demand keynote presentations and related Q&A, scheduled on October 5 and 7, respectively. Virtual delegates will be able to attend presentations from top international speakers, submit questions in real time, network and chat with their online peers, and navigate the show via a virtual fully interactive platform. Registration for the Vaccine Virtual Congress is free for the first 250 registrants.
Search for more such STM conferences in K-Store
Discuss this NEWS
